Cataract Surgery · Systemic Disease
Diabetes and cataract:
two problems,
one eye.
Diabetes clouds the lens earlier, and it can also damage the retina behind it. A new lens fixes the first problem but not the second, so the real question before surgery is rarely “is the cataract ready?” but “what is the retina doing?” Here is how surgeons work that out.
live with diabetes
shapes the plan
scan before surgery
Section 01 — Two Problems
The lens clouds.
The retina may
be damaged too.
Most people with diabetes who need cataract surgery do well. But the eye they are bringing to the operating table is not a standard one: the lens has often clouded earlier, the pupil may open less, and the retina behind it may already carry diabetic damage. Cataract surgery treats only the first of those.
Diabetes has long been associated with earlier and more frequent cataract. Population studies such as the Beaver Dam Eye Study found more lens opacity in people with diabetes, and the lens changes are thought to be driven in part by excess glucose being converted to sorbitol inside the lens fibres, which draws in water and disturbs lens clarity. In some young people with poorly controlled type 1 diabetes, a rapidly developing “snowflake” cataract can appear over weeks to months, although that pattern is uncommon.
The surgery itself is the same operation. What changes is the risk profile around it: the macula is more likely to swell afterwards, the retina may need treatment before or after, and the surgeon has to protect the view of the back of the eye for future laser or injections.
Cataract surgery is generally safe and effective in people with diabetes, and for most the vision gain is real. What decides the outcome is usually the retina, not the lens: eyes with no or mild retinopathy tend to do well, while eyes with diabetic macular oedema (DME) or active proliferative disease are more likely to have swelling, slower recovery and a lower final vision. That is why surgeons check the retina and the macula with OCT first, treat significant DME or high-risk disease before surgery where time allows, use a careful anti-inflammatory plan afterwards, and keep reviewing the retina long after the cataract is gone.
Section 02 — Interactive
Same cataract.
Very different retinas.
Move the slider through the four broad retinal states a surgeon meets in diabetic cataract patients. Watch the red lesions build up on the back wall and the macula (the gold disc at the centre) thicken once fluid reaches it. Then switch on retinal treatment to see why surgeons try to calm the retina first.
Notice what does not change as you move the slider: the lens. The cataract is the same in all four. That is the point of the model. The lens decides how blurred the view is today; the retina decides how much vision is available once that blur is removed.
Section 03 — Before Surgery
The work-up that
actually changes the plan.
In a diabetic patient the pre-operative checklist is longer than the usual cataract one, and most of the extra items are about the retina and the iris, not the lens.
| Check | Why it matters in diabetes |
|---|---|
| Dilated retinal exam | Grades retinopathy and finds treatable disease. If the cataract is dense the view may be poor, so ultrasound of the back of the eye can fill the gap. |
| Macular OCT | Shows whether the macula is already thickened. A baseline scan also lets later swelling be recognised and measured against it. |
| Iris and angle exam | New vessels on the iris or in the drainage angle signal active proliferative disease and raise the risk of bleeding and pressure rise. |
| Pupil dilation | Poor dilation is more common, so the surgeon plans for a small pupil rather than discovering it mid-operation. |
| Glycaemic and blood-pressure review | Surgeons look at overall control and trend. There is no single universal HbA1c cut-off, and delaying a needed operation indefinitely has its own cost. |
| Cornea and eye surface | Diabetic corneas can be slower to heal and more sensitive to the surgical insult, which influences how much work is done inside the eye. |
Section 04 — In the Operating Room
Gentle on the iris,
generous with
the opening.
The surgical steps are the familiar ones. The adjustments are in how much the eye is disturbed and in keeping the retina visible for the future.
Choosing the implant
In most diabetic eyes a standard monofocal intraocular lens (IOL) is the sensible default. Surgeons commonly prefer a hydrophobic acrylic lens with a decent optic size so the periphery of the retina can still be examined and lasered later. A silicone IOL is often avoided in eyes that might need a vitrectomy with silicone oil in future, because oil can adhere to silicone lenses and cloud the view.
Multifocal and extended-depth-of-focus lenses are usually approached cautiously, or avoided, when there is significant retinopathy or macular disease. These designs spread light between focal points, which lowers contrast sensitivity, and a diseased macula already has less contrast to spare. The trade-off is covered in the complete IOL choice guide.
Section 05 — The Evidence
What the studies
say about macular swelling.
The data are consistent on direction and wary on precision. Diabetic eyes, and above all eyes with existing retinopathy or maculopathy, are more likely to develop macular oedema after cataract surgery. Exact rates differ by study, population and definition, which is why this guide does not quote one.
A UK electronic-medical-record study led by Chu and colleagues analysed roughly 80,000 eyes and reported that diabetes, and particularly retinopathy, were among the strongest risk factors for macular oedema after cataract surgery. Dowler and colleagues followed diabetic patients after surgery and found that pre-existing maculopathy made post-operative macular oedema more likely and more likely to persist. The Early Treatment Diabetic Retinopathy Study (ETDRS) also reported on outcomes after lens extraction in its participants, with good visual results overall but outcomes that depended on how much retinopathy and macular oedema were present beforehand.
Prevention has been tested directly. The ESCRS PREMED trials compared anti-inflammatory regimens (topical steroid, topical NSAID and, in diabetic eyes, whether an intravitreal agent added benefit) to prevent post-operative macular oedema. Protocols still differ between surgeons, and the results are nuanced enough that the details belong in the original reports rather than in a summary line. The post-operative side of this problem is covered in cystoid macular oedema after cataract surgery.
Section 06 — After Surgery
Recovery is the same.
Surveillance is not.
The first days look like anyone else’s recovery. The difference is the longer tail: a diabetic eye is watched for macular swelling for weeks to months, and the retinal follow-up continues for life.
| Stage | What usually happens |
|---|---|
| First days | Anti-inflammatory and antibiotic drops as prescribed. Blood sugar is monitored as usual, and any diabetes medication change should follow the clinic’s instructions, not guesswork. |
| First weeks | A repeat macular OCT is common, particularly if there was retinopathy or vision is lower than expected. Many surgeons extend the drop course in higher-risk eyes. |
| If macular oedema appears | Treated with drops, injections or laser depending on type and severity. Most responds, but it can take weeks to months. |
| Long term | Regular dilated retinal exams continue. The posterior capsule can cloud later in any eye and is treated with a quick laser (see PCO after cataract surgery). |
A person with long-standing type 2 diabetes has a visible cataract and a blurry left eye. A pre-operative OCT shows mild macular thickening that the cloudy lens had been hiding from the examiner. The surgeon refers the patient for retinal treatment first, then operates once the macula has flattened, with a closely monitored anti-inflammatory course afterwards. Vision improves substantially, though not to the same level as a healthy eye, because the retina was part of the original problem.
Section 07 — The Agaaz Range
What sits in the tray
for a diabetic eye.
Agaaz Ophthalmics makes nothing specific to diabetic eyes, and this guide does not claim any product treats diabetic disease or prevents macular oedema. The consumables below are the general intraocular range used in any cataract case, listed here because several of the surgical priorities above, a visible capsule, a protected endothelium and infection prophylaxis, map onto them. Product choice stays with the surgeon.
Section 08 — FAQ
Frequently asked questions
about diabetes and cataract surgery.
Yes, for most people. Cataract surgery is generally safe and effective in diabetes, and most patients gain useful vision. The risks that are higher than average are swelling of the macula, slower healing and, in eyes with advanced retinopathy, a lower final vision because the retina is part of the problem. Careful pre-operative assessment of the retina and a planned anti-inflammatory course afterwards are what keep those risks in check.
Studies disagree on whether the operation itself speeds up retinopathy, and the evidence is not strong enough to give a single figure. What is consistent is that eyes with existing retinopathy or macular oedema are more likely to develop macular swelling after surgery, and that the retina's condition before surgery is the best predictor of what follows. That is why surgeons grade the retina and scan the macula first, and treat significant disease before operating where time allows.
Population studies link diabetes to more and earlier lens opacity. The lens changes are thought to be driven partly by excess glucose being converted to sorbitol inside the lens fibres, which pulls in water and disturbs clarity, alongside oxidative stress over time. In some young people with poorly controlled type 1 diabetes a rapidly developing snowflake cataract can appear, although that is uncommon.
Good control helps, and surgeons review overall control, trend and blood pressure before operating. There is no single universal HbA1c cut-off that applies to every clinic, and postponing a needed operation indefinitely carries its own cost in lost vision and falls risk. Follow your clinic's instructions on diabetes medication and fasting for the day of surgery rather than adjusting doses yourself.
A standard monofocal lens is the usual default. Surgeons commonly favour a hydrophobic acrylic lens with an adequate optic size so the retina can still be examined and treated later, and often avoid silicone lenses in eyes that might need silicone oil in future. Multifocal and extended-depth-of-focus lenses are approached cautiously, or avoided, when retinopathy or macular disease is present because they lower contrast sensitivity. The final choice belongs to your surgeon.
Only some patients do. If the macula is thickened or there is high-risk proliferative disease, a retina specialist may treat it before surgery, around the time of surgery or soon afterwards, depending on how clear a view of the retina is available. If the retina is healthy or only mildly affected, no retinal treatment is usually needed. Your pre-operative retinal exam and OCT scan decide which group you are in.
The first days look like any cataract recovery, with prescribed drops and limited rubbing or pressure on the eye. In diabetic eyes the macula is then watched for several weeks to months, often with a repeat OCT scan, and the longer retinal follow-up continues for life. Contact the clinic the same day for pain, increasing redness, a sudden drop in vision, or a new curtain or shower of floaters.
References & Evidence Base
Peer-reviewed
citations.
Continue Reading
Related guides
from Beyond Vision.
Start writing here...
